Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 26,339,960 $ 26,287,293
Accounts receivable, net 100,935 143,353
Inventory 71,597 105,821
Prepaid expenses and other current assets 649,479 827,551
Total current assets 27,161,971 27,364,018
Property and equipment, net 383,238 429,035
Operating lease right-of-use assets 1,778,512 1,959,869
Total assets 29,323,721 29,752,922
Current liabilities:    
Accounts payable 1,351,018 900,765
Accrued expenses 1,370,046 1,790,414
Accrued severance expense 249,610 416,516
Warrant liability 3,135,000  
Operating lease liabilities, current portion 702,780 705,894
Deferred revenue 35,891 29,727
Total current liabilities 6,844,345 3,843,316
Operating lease liabilities, long-term portion 1,090,639 1,264,131
Total liabilities 7,934,984 5,107,447
Commitments and contingencies
Stockholders’ equity:    
Preferred Stock, $0.00001 par value, 10,000,000 shares authorized at March 31, 2023 and December 31, 2022; no shares issued or outstanding at March 31, 2023 and December 31, 2022.
Common Stock, $0.00001 par value, 200,000,000 shares authorized at March 31, 2023 and December 31, 2022; 91,032,030 and 78,944,954 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively. 911 789
Additional paid-in capital 390,715,632 387,319,985
Accumulated deficit (369,327,806) (362,675,299)
Total stockholders’ equity 21,388,737 24,645,475
Total liabilities and stockholders’ equity $ 29,323,721 $ 29,752,922